Showing results (281-290 of 308) with videos related to

Sort By:
Pageof 31
Journal of Cardiovascular Pharmacology|April 9, 2004
Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefitsVictor L Serebruany, Alex I Malinin, David R Lowry, et al.
The American Journal of Cardiology|May 4, 2012
Effect of glycemic control on response to antiplatelet therapy in patients with diabetes mellitus and ST-segment elevation myocardial infarctionWiktor Kuliczkowski, Mariusz Gąsior, Damian Pres, et al.
Thrombosis and Haemostasis|February 19, 2016
Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulationVictor L Serebruany, Seth D Fortmann, Sunil V Rao, et al.
International Journal of Cardiology|November 26, 2015
Concomitant nitrates enhance clopidogrel response during dual anti-platelet therapyDong Hyun Lee, Moo Hyun Kim, Long Zhe Guo, et al.
Cardiology Research and Practice|February 23, 2013
The CYP2C19(∗)1/(∗)2 Genotype Does Not Adequately Predict Clopidogrel Response in Healthy Malaysian VolunteersYanti Nasyuhana Sani, Lim Sheau Chin, Lim Luen Hui, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2003
Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy)Paul A Gurbel, Brian Galbut, Kevin P Bliden, et al.
Thrombosis and Haemostasis|March 3, 2017
Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA)Victor L Serebruany, Moo Hyun Kim, Hector A Cabrera-Fuentes, et al.
Pageof 31